⌘K

Home/Filings/4/0000921895-23-002392

4//SEC Filing

Ben-Tzvi Avraham 4

Accession 0000921895-23-002392

CIK 0000910267other

View on SEC.gov Company Profile

Filed

Oct 25, 8:00 PM ET

Accepted

Oct 26, 4:23 PM ET

Size

4.8 KB

Accession

0000921895-23-002392

Insider Transaction Report

Form 4

Period: 2023-10-25

TITAN PHARMACEUTICALS INCTTNP

Ben-Tzvi Avraham

Director

Transactions

Award
Common Stock
2023-10-25+16,250→ 66,250 total

Footnotes (1)

[F1]The shares reported in this transaction represent Unrestricted Stock Awards pursuant to the Issuer's Fourth Amended and Restated 2015 Omnibus Equity Incentive Plan that vested immediately on the date of grant.

Documents

1 file

4
form413531002ben_10262023.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

TITAN PHARMACEUTICALS INC

CIK 0000910267

Entity typeother

Related Parties

1

filerCIK 0001944721

Filing Metadata

Form type: 4
Filed: Oct 25, 8:00 PM ET
Accepted: Oct 26, 4:23 PM ET
Size: 4.8 KB

View on SEC.gov